Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 1 Device Recall

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 1 Device Recallsee related information
Date Initiated by FirmMay 05, 2004
Date PostedJuly 20, 2004
Recall Status1 Terminated 3 on July 24, 2007
Recall NumberZ-1021-04
Recall Event ID 29061
ProductCOBAS Gui software interface between the Cobas AMPLICOR instrument and the Tecan clinical workstation (Tecan Genesis 150/8 front end COBAS), Roche catalog number 04498984001.
Code Information All units (serial numbers 6178, 7629, 7698, 7744, 7753, 7754, 7755 and 7768 .
FEI Number 1823260
Recalling Firm/
Manufacturer		 Roche Diagnostics Corp.
9115 Hague Rd
Indianapolis IN 46256-1025
For Additional Information Contact
800-526-1247
Manufacturer Reason
for Recall		The Roche COBAS interface driver for the Tecan software may assign sample results to the wrong patient.
FDA Determined
Cause 2		Other
ActionPress release was issued 5/7/04 and recall letter dated 5/5/04 was sent to each user consignee.
Quantity in Commerce8
DistributionCalifornia, Connecticut, Illinois, Massachusetts Pennsylvania, Texas and Wisconsin.
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 �7.55.
-
-